Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trialXiaohua Wu, Linjuan Zeng, Zhongqiu Lin et al.|Nature Medicine|2024Cited by 41
Abstract 3318: Development of a cfDNA based trans-omics approach for early cancer detectionYuying Wang, Mingzhi Ye, Heng Zhao et al.|Prevention, Early Detection, and Interception|2019Cited by 0